Company · VRTX
VERTEX PHARMACEUTICALS INC / MA
In the 12 months to Nov 19, 2026: insiders sold on 19 occasions ($27.5M); 10 planned-sale notices; 1 filing by holders of 5% or more; 3 congressional trade disclosures; 5 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Bozic Carmen, EVP and CMO sold $9.1M
- WAGNER CHARLES F JR, EVP, CO & FO sold $8.4M
- Kewalramani Reshma, CEO & President sold $6.3M
- Liu Joy, EVP and Chief Legal Officer sold $1.2M
- McKechnie Duncan, EVP, Chief Commercial Officer sold $800K
- Tatsis Ourania, EVP, Chief Reg. & Quality Off. sold $787K
- Thornberry Nancy sold $548K
- Bhatia Sangeeta N. sold $283K
- Bunnage Mark E., EVP, Chief Scientific Officer sold $15K
Every trade (19)
- SELLThornberry Nancy sold $548K
- SELLBhatia Sangeeta N. sold $148K
- SELLWAGNER CHARLES F JR, EVP, CO & FO sold $8.4M
- SELLKewalramani Reshma, CEO & President sold $6.3M
- SELLMcKechnie Duncan, EVP, Chief Commercial Officer sold $800K
- SELLTatsis Ourania, EVP, Chief Reg. & Quality Off. sold $787K
- SELLLiu Joy, EVP and Chief Legal Officer sold $416K
- SELLBozic Carmen, EVP and CMO sold $288K
- SELLBozic Carmen, EVP and CMO sold $471K
- SELLBozic Carmen, EVP and CMO sold $1.8M
- SELLBozic Carmen, EVP and CMO sold $785K
- SELLLiu Joy, EVP and Chief Legal Officer sold $364K
- SELLBozic Carmen, EVP and CMO sold $888K
- SELLBozic Carmen, EVP and CMO sold $614K
- SELLBunnage Mark E., EVP, Chief Scientific Officer sold $15K
- SELLBozic Carmen, EVP and CMO sold $3.1M
- SELLBhatia Sangeeta N. sold $135K
- SELLLiu Joy, EVP and Chief Legal Officer sold $469K
- SELLBozic Carmen, EVP and CMO sold $1.1M
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- Thornberry Nancy $548K
- Bhatia Sangeeta N. $148K
- WAGNER CHARLES F JR $8.4M
- Kewalramani Reshma $6.3M
- Bruce I. Sachs $663K
- McKechnie Duncan $800K
- Tatsis Ourania $787K
- Liu Joy $416K
- Bozic Carmen $288K
- Bozic Carmen $471K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Capital Research Global Investors 7%
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- David J. Taylor (R-OH02): Sale $1,001 - $15,000
- Alan Armstrong (R-OK): Purchase $1,001 - $15,000
- David J. Taylor (R-OH02): Sale $1,001 - $15,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Nov 2, 2026
- Departure or appointment of directors or officers Oct 20, 2026
- Departure or appointment of directors or officers Sep 1, 2026
- Results of operations and financial condition Aug 3, 2026
- Entry into a material definitive agreement; Regulation FD disclosure; Other events Jul 7, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.